Downloadable Slideset

Share

Program Content

Activities

  • Antibody-based Tx in AML
    Targeting Antigens in AML: New Advances in Antibody–Drug Conjugate and Other Antibody-Based Therapies
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2018

    Expires: December 03, 2019

  • ND AML: Optimal Treatment
    Overcoming Treatment Challenges in Patients With Newly Diagnosed AML
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2018

    Expires: December 04, 2019

  • Treating <i>FLT3</i> AML
    Treating Patients With FLT3-Mutated Acute Myeloid Leukemia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2018

    Expires: December 03, 2019

  • Treating <i>IDH1/2</i> AML
    Available and Emerging Treatment Options in IDH-Mutant AML
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2018

    Expires: December 04, 2019

  • Emerging Agents in AML
    Exploring New Therapeutic Frontiers in AML: Emerging Molecular Targets
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2018

    Expires: December 04, 2019

Provided by

ProCE Banner

Supporters

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation